Gabriel Leung has an estimated net worth of $31.6 Million. This is based on reported shares across multiple companies, which include NovoCure Ltd, DELCATH SYSTEMS INC, ALBANY MOLECULAR RESEARCH INC, PERNIX THERAPEUTICS HOLDINGS, INC., and OSI PHARMACEUTICALS INC.

2019 was Gabriel Leung's most active year for acquiring shares with 25 total transactions. Gabriel Leung's most active month to acquire stocks was the month of May. 2004 was Gabriel Leung's most active year for disposing of shares, totalling 60 transactions. Gabriel Leung's most active month to dispose stocks was the month of June. 2004 saw Gabriel Leung paying a total of $1,898,937.19 for 105,710 shares, this is the most they've acquired in one year. In 2010 Gabriel Leung cashed out on 324,420 shares for a total of $16,076,166.21, their largest year based on trade value.